Casey Lynch

Insider Reports History

Entity
Individual
Location
C/O Cortexyme, Inc., 269 East Grand Ave., South San Francisco, CA
Signature
/s/ Andrew J. Cronauer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Casey Lynch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cortexyme, Inc. Chief Executive Officer, Director Stock Option (right to buy) 440K Jan 3, 2022 Direct
Longboard Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 22.5K May 23, 2024 Direct
Longboard Pharmaceuticals, Inc. Director Employee Stock Option (right to buy) 0 Dec 2, 2024 Direct

Insider Reports Filed by Casey Lynch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LBPH Longboard Pharmaceuticals, Inc. Dec 2, 2024 5 $0 4 Dec 2, 2024 Director
LBPH Longboard Pharmaceuticals, Inc. May 23, 2024 1 $0 4 May 24, 2024 Director
LBPH Longboard Pharmaceuticals, Inc. May 25, 2023 1 $0 4 May 26, 2023 Director
LBPH Longboard Pharmaceuticals, Inc. May 24, 2022 1 $0 4 May 31, 2022 Director
QNCX Cortexyme, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Executive Officer, Director
QNCX Cortexyme, Inc. Nov 18, 2021 2 $27.6K 4 Nov 19, 2021 Chief Executive Officer, Director
QNCX Cortexyme, Inc. May 10, 2021 4 -$1.04M 4 May 12, 2021 Chief Executive Officer, Director